MINERVA BIOTECHNOLOGIES
Minerva Biotechnologies develops cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis. Its stem cell technology could transform the field of regenerative medicine. It discovered that cancer cells are healthy cells that are being reprogrammed back to a stem cell state. It is also the first company to generate human naïve state pluripotent stem cells using a single, naturally occurring human stem cell growth factor. These earlier stem cells have a clean slate and are more easily directed to develop into functional mature cells, which could be used for transplant. It was founded in 1999 and is headquartered in Waltham, Massachusetts.
MINERVA BIOTECHNOLOGIES
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
1999-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.minervabio.com
Total Employee:
11+
Status:
Active
Contact:
+1 781-487-0200
Email Addresses:
[email protected]
Total Funding:
65.51 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apache Mobile Non Scaleable Content Organization Schema Google Maps AJAX Libraries API
Similar Organizations
Candel Therapeutics
Candel Therapeutics develops cancer immunotherapies designed to improve the lives of cancer patients and their families.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.minervabio.com Semrush global rank: 9.73 M Semrush visits lastest month: 114
- Host name: 162-215-248-62.unifiedlayer.com
- IP address: 162.215.248.62
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Minerva Biotechnologies"
We See the Future First | Minerva Biotechnologies
Minerva Biotechnologies is focused on cancer and stem cell therapeutics. We are developing cancer immunotherapies targeting 80% of solid tumors and to prevent cancer metastasis. …See details»
About Us | Minerva Biotechnologies
Minerva Biotechnologies is a privately held biotech company founded in 1999, located on Bear Hill Rd, Waltham, MA. The Company has 15 years of solid research that is now poised for …See details»
Management Team | Minerva Biotechnologies
At Minerva, Mr. Axelrod is responsible for corporate development, investor relations, facilities and operations, accounting and finance, IT, and procurement.See details»
Minerva Biotechnologies - Crunchbase Company …
Minerva Biotechnologies develops cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis. View contacts for Minerva Biotechnologies to access new leads and connect with decision-makers.See details»
Minerva Biotechnologies - LinkedIn
Minerva Biotechnologies is a clinical stage biopharmaceutical company focused on developing immunotherapies for solid tumor cancers and cellular therapies for regenerative medicine.See details»
Minerva Biotechnologies Announces License …
Jun 22, 2020 · Minerva Biotechnologies announces that it has licensed from Memorial Sloan Kettering Cancer Center (MSK) “1XX” technology for use with Minerva’s anti-MUC1* antibodies to increase CAR T cell...See details»
Minerva Biotechnologies - Overview, News & Similar companies
Jun 22, 2020 · View Minerva Biotechnologies (www.minervabio.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well …See details»
Minerva Biotechnologies, Interview with CEO Dr.
Jun 4, 2019 · Minerva Biotechnologies is a regenerative medicine company specializing in stem cell therapeutics that is developing cancer immunotherapies to target 75% of solid tumors and to prevent cancer metastasis. I had the …See details»
Minerva Biotechnologies - PitchBook
Developer of cancer immunotherapies and cancer drugs intended to target solid tumors and prevent cancer metastasis. The company's drugs generate human naïve state-induced pluripotent stem cells, enabling researchers to design …See details»
Minerva Biotechnologies - Craft
Minerva Biotechnologies is a company focused on cancer and stem cell therapeutics. It develops cancer immunotherapies targeting solid tumors and preventing cancer metastasis. The …See details»
Board & Advisors | Minerva Biotechnologies
Dr. Bamdad is the Chief Executive Officer and Chief Scientific Officer of Minerva Biotechnologies. She was a pioneer in the field of biochips and is now recognized as a leader in the field of cancer stem cells and cancer immunotherapy. Dr.See details»
Minerva Biotechnologies - VentureRadar
Website: http://www.minervabio.com Develops clinical-stage cancer treatments with a near-term pipeline, including huMNC2-CAR44 T cells in Phase I/II trial for metastatic breast cancers. …See details»
Streamlit
You need to enable JavaScript to run this app. Streamlit. You need to enable JavaScript to run this app.See details»
Minerva Biotechnologies CEO and Key Executive Team | Craft.co
Minerva Biotechnologies's COO is Ron Axelrod. See the full leadership team at Craft.See details»
Minerva Biotechnologies Announces License Agreement with
Jun 22, 2020 · WALTHAM, Mass.-- ( BUSINESS WIRE )-- Minerva Biotechnologies Corporation (Minerva) today announced that it has licensed from Memorial Sloan Kettering Cancer Center …See details»
Cancer Therapeutics | Minerva Biotechnologies
Minerva Biotechnologies is developing cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis. As a company, we are modality agnostic – …See details»
Working at MINERVA BIOTECHNOLOGIES - Glassdoor
Minerva Biotechnologies is developing cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis. Our stem cell technology could transform …See details»
Contamination Detection & Control | Minerva Biolabs
We elaborate cutting-edge detection & elimination strategies for contamination control. Would you like to try our products first? We offer samples for many of our products free of charge. …See details»
Universal Gold Nanoparticle Platform for Protein-Protein …
Imaging of nanoparticles was performed by transmission electron microscopy on a JEOL 1200ex (Harvard Medical School) and images analyzed by ImageJ (available for free at: …See details»
Science News - Minerva Biotechnologies | Minerva Biotechnologies
WALTHAM, MA - Minerva Biotechnologies, a biopharmaceutical company focused on developing immunotherapies for cancer and cellular therapies in regenerative medicine, announced ...See details»